TELA BIO, INC.

TELA BIO, INC. specializes in the design, manufacture, and supply of advanced surgical implants and medical devices, with a focus on biologic mesh products, permanent tissue repair solutions, and prosthetic systems used in reconstructive and hernia repair procedures. Their technical expertise lies in biomaterial engineering, implantable textile technologies, and sterile manufacturing processes compliant with FDA and ISO standards for Class II medical devices. The company differentiates itself through proprietary tissue reinforcement platforms, including permanent synthetic meshes and specialized surgical meshes engineered for long-term biocompatibility and structural integrity in complex abdominal and soft tissue applications. Their product portfolio supports minimally invasive and open surgical techniques, with an emphasis on durable, patient-specific implant solutions. The Department of Veterans Affairs is the primary federal partner, consistently procuring surgical implants and medical instruments to support veteran healthcare needs across VA medical centers. TELA BIO, INC. delivers critical surgical supplies for reconstructive, urological, and general surgery programs, indicating a deep integration into VA’s surgical supply chain and a trusted relationship for high-volume, mission-critical implant procurement. The company’s industry focus centers on surgical appliance and medical instrument manufacturing, specifically NAICS 339113 and 339112, which encompass the production of implantable tissue repair systems, permanent surgical meshes, and specialized prosthetic components. Their market positioning is that of a niche supplier to the U.S. government healthcare system, serving as a reliable source for high-performance, regulated surgical implants that meet stringent clinical and regulatory requirements. TELA BIO, INC. is a small business entity headquartered in Malvern, Pennsylvania, with no federal certifications disclosed. The company operates as a specialized manufacturer with a focused government market presence, serving federal healthcare providers through direct procurement channels and established supply agreements. Their geographic footprint is centered on U.S. federal medical facilities, with no indication of international or commercial market expansion based on available award data.